Article
Restoration of p53 to limit tumor growth.
Current opinion in oncology - 1 Jan 2008
Wang Wenge, El-Deiry Wafik S
Abstract excerpt
PURPOSE OF REVIEW: p53 mutation occurs in over half of all human tumors. Among the remaining tumors, although they may process a wild-type p53, the pathways of p53-induced cell-cycle arrest and apoptosis are deficient. Therefore, p53 serves as a unique molecular target for cancer therapy. This review focuses on the current progress regarding restoration of p53 function in human tumors for molecularly targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
